Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Gibson

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Inorganic Chemistry Frontiers|January 18, 2024
Stepwise optimization of tumor-targeted dual-action platinum(iv)-gemcitabine prodrugsAlexander Kastner, Theresa Mendrina, Tomer Babu, et al.
BMC Genomics|December 25, 2015
Transcriptomes of post-mitotic neurons identify the usage of alternative pathways during adult and embryonic neuronal differentiationAlexandra Tallafuss, Meghan Kelly, Leslie Gay, et al.
Dalton Transactions (Cambridge, England : 2003)|April 4, 2022
Study of the DNA binding mechanism and <i>in vitro</i> activity against cancer cells of iron(III) and aluminium(III) kojic acid derivative complexesJoanna I Lachowicz, Anna Mateddu, Pierpaolo Coni, et al.
Journal of Medicinal Chemistry|April 30, 2019
A Subset of New Platinum Antitumor Agents Kills Cells by a Multimodal Mechanism of Action Also Involving Changes in the Organization of the Microtubule CytoskeletonHana Kostrhunova, Juraj Zajac, Vojtech Novohradsky, et al.
Advanced Healthcare Materials|May 22, 2024
Fluorescence-Guided Spatial Drug Screening in 3D Colorectal Cancer SpheroidsJia Ning Nicolette Yau, Thirumal Yempala, Ram Pravin Kumar Muthuramalingam, et al.
Angewandte Chemie (International Ed. in English)|April 5, 2019
Dual-Targeting Dual-Action Platinum(IV) Platform for Enhanced Anticancer Activity and Reduced NephrotoxicityMaria V Babak, Yang Zhi, Bertrand Czarny, et al.
Angewandte Chemie (International Ed. in English)|October 6, 2025
A Triple Threat Against Ovarian Cancer: Os(II)-Pt(IV)-Ceritinib Conjugates for Photodynamic Therapy, Chemotherapy, and Immunogenic Cell Death InductionMarta Redrado, Sourav Acharya, Pierre Mesdom, et al.
Angewandte Chemie (International Ed. in English)|January 11, 2023
Oral Anticancer Heterobimetallic Pt<sup>IV</sup> -Au<sup>I</sup> Complexes Show High In Vivo Activity and Low ToxicityTomer Babu, Hiba Ghareeb, Uttara Basu, et al.
The Journal of Animal Ecology|May 23, 2022
A hierarchical model for jointly assessing ecological and anthropogenic impacts on animal demographyThomas V Riecke, Benjamin S Sedinger, Todd W Arnold, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 8, 2026
Is platinum the New gold? Re-evaluating platinum's enduring role and future potential in the era of novel ovarian cancer therapiesAndres Pachon Roa, Ram Pravin Kumar Muthuramalingam, Alvaro Lopez-Sanchez, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Inorganic Chemistry Frontiers|January 18, 2024
Stepwise optimization of tumor-targeted dual-action platinum(iv)-gemcitabine prodrugsAlexander Kastner, Theresa Mendrina, Tomer Babu, et al.
BMC Genomics|December 25, 2015
Transcriptomes of post-mitotic neurons identify the usage of alternative pathways during adult and embryonic neuronal differentiationAlexandra Tallafuss, Meghan Kelly, Leslie Gay, et al.
Dalton Transactions (Cambridge, England : 2003)|April 4, 2022
Study of the DNA binding mechanism and <i>in vitro</i> activity against cancer cells of iron(III) and aluminium(III) kojic acid derivative complexesJoanna I Lachowicz, Anna Mateddu, Pierpaolo Coni, et al.
Journal of Medicinal Chemistry|April 30, 2019
A Subset of New Platinum Antitumor Agents Kills Cells by a Multimodal Mechanism of Action Also Involving Changes in the Organization of the Microtubule CytoskeletonHana Kostrhunova, Juraj Zajac, Vojtech Novohradsky, et al.
Advanced Healthcare Materials|May 22, 2024
Fluorescence-Guided Spatial Drug Screening in 3D Colorectal Cancer SpheroidsJia Ning Nicolette Yau, Thirumal Yempala, Ram Pravin Kumar Muthuramalingam, et al.
Angewandte Chemie (International Ed. in English)|April 5, 2019
Dual-Targeting Dual-Action Platinum(IV) Platform for Enhanced Anticancer Activity and Reduced NephrotoxicityMaria V Babak, Yang Zhi, Bertrand Czarny, et al.
Angewandte Chemie (International Ed. in English)|October 6, 2025
A Triple Threat Against Ovarian Cancer: Os(II)-Pt(IV)-Ceritinib Conjugates for Photodynamic Therapy, Chemotherapy, and Immunogenic Cell Death InductionMarta Redrado, Sourav Acharya, Pierre Mesdom, et al.
Angewandte Chemie (International Ed. in English)|January 11, 2023
Oral Anticancer Heterobimetallic Pt<sup>IV</sup> -Au<sup>I</sup> Complexes Show High In Vivo Activity and Low ToxicityTomer Babu, Hiba Ghareeb, Uttara Basu, et al.
The Journal of Animal Ecology|May 23, 2022
A hierarchical model for jointly assessing ecological and anthropogenic impacts on animal demographyThomas V Riecke, Benjamin S Sedinger, Todd W Arnold, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 8, 2026
Is platinum the New gold? Re-evaluating platinum's enduring role and future potential in the era of novel ovarian cancer therapiesAndres Pachon Roa, Ram Pravin Kumar Muthuramalingam, Alvaro Lopez-Sanchez, et al.
Pageof 9